DrugDashboards

Midazolam

Midazolam · MIDAZOLAM HYDROCHLORIDE 1 mg/mL · Injection, Solution · Intramuscular; Intravenous · Micro Labs Limited

NDC 42571-0414-87 · 25 VIAL in 1 CARTON / 2 mL in 1 VIAL · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for midazolam (injectable) in the next 90 days

sterile injectable · sole-source market · price up 3% YoY

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $941.02 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA217504
TE code
AP
Approval date
Aug 21, 2023
Patents / exclusivity
None on file

Shortage history

  • In shortage now Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)Apr 2, 2020
    month 78 — 4× the typical 20-month injectable shortage
  • In shortage now Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)Apr 2, 2020
    month 78 — 4× the typical 20-month injectable shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Midazolam (Injection, Solution)

LabelerStrengthFirst seenLast seen
Henry Schein, Inc.MIDAZOLAM HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Micro Labs LimitedMIDAZOLAM HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026
Micro Labs LimitedMIDAZOLAM HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLC.MIDAZOLAM 1 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Midazolam — NDC 42571-0414-87," retrieved September 3, 2026, https://drugdashboards.com/drug/42571041487.

Free to cite with attribution — see how the data is put together.